Abstract
Cefotaxime has little antimicrobial activity in vitro against most strains of enterococci, as measured by conventional MICs and MBCs. However, the MICs of cefotaxime against many enterococci are markedly reduced by the addition of serum to the test medium. To assess the relevance of this observation in vivo, we examined the efficacy of cefotaxime in experimental Streptococcus faecalis endocarditis. Since response to antimicrobial agents may vary with the degree of vegetation development, therapeutic efficacy was assessed both in rabbits with newly formed vegetations and in rabbits with well-developed endocardial lesions. Peak serum levels of cefotaxime (50.1 +/- 20.0 micrograms/ml) exceeded the MIC in medium supplemented with serum (4 micrograms/ml), but not in Mueller-Hinton broth alone (greater than 64 micrograms/ml). After 4 days of therapy, animals with newly formed lesions (therapy initiated 1 h after infection, transvalvular catheters removed) had lower mean vegetation bacterial titers than did untreated controls. Among animals with mature vegetations (therapy initiated 12 h after infection, catheters indwelling), the rate of mortality was significantly reduced by cefotaxime therapy. However, no difference in vegetation titers was observed. Thus, cefotaxime demonstrated antienterococcal activity within newly formed vegetations, but did not inhibit bacterial proliferation within well-established vegetations.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Durack D. T., Beeson P. B. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol. 1972 Feb;53(1):44–49. [PMC free article] [PubMed] [Google Scholar]
- Durack D. T., Beeson P. B. Experimental bacterial endocarditis. II. Survival of a bacteria in endocardial vegetations. Br J Exp Pathol. 1972 Feb;53(1):50–53. [PMC free article] [PubMed] [Google Scholar]
- Freedman L. R., Valone J., Jr Experimental infective endocarditis. Prog Cardiovasc Dis. 1979 Nov-Dec;22(3):169–180. doi: 10.1016/0033-0620(79)90021-5. [DOI] [PubMed] [Google Scholar]
- Gutschik E. Experimental endocarditis in rabbits. 6. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and streptomycin. Acta Pathol Microbiol Immunol Scand B. 1982 Feb;90(1):37–47. [PubMed] [Google Scholar]
- Lorian V., Zak O., Kunz S., Vaxelaire J. Staphylococcal endocarditis in rabbits treated with a low dose of cloxacillin. Antimicrob Agents Chemother. 1984 Mar;25(3):311–315. doi: 10.1128/aac.25.3.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moellering R. C., Jr, Eliopoulos G. M. Activity of cefotaxime against enterococci. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):85S–90S. [PubMed] [Google Scholar]
- Moellering R. C., Jr, Korzeniowski O. M., Sande M. A., Wennersten C. B. Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis. 1979 Aug;140(2):203–208. doi: 10.1093/infdis/140.2.203. [DOI] [PubMed] [Google Scholar]
- Panwalker A. P., Rosenfeld J. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam. J Infect Dis. 1983 Jan;147(1):171–172. doi: 10.1093/infdis/147.1.171. [DOI] [PubMed] [Google Scholar]
- Perlman B. B., Freedman L. R. Experimental endocarditis. 3. Natural history of catheter induced staphylococcal endocarditis following catheter removal. Yale J Biol Med. 1971 Oct;44(2):214–224. [PMC free article] [PubMed] [Google Scholar]
- Perlman B. B., Freedman L. R. Experimental endocarditis. II. Staphylococcal infection of the aortic valve following placement of a polyethylene catheter in the left side of the heart. Yale J Biol Med. 1971 Oct;44(2):206–213. [PMC free article] [PubMed] [Google Scholar]
- Reimer L. G., Stratton C. W., Reller L. B. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum. Antimicrob Agents Chemother. 1981 Jun;19(6):1050–1055. doi: 10.1128/aac.19.6.1050. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sande M. A., Irvin R. G. Penicillin-aminoglycoside synergy in experimental Streptococcus viridans endocarditis. J Infect Dis. 1974 May;129(5):572–576. doi: 10.1093/infdis/129.5.572. [DOI] [PubMed] [Google Scholar]
- Stevens P., Young L. S. Simple method for elimination of aminoglycosides from serum to permit bioassay of other antimicrobial agents. Antimicrob Agents Chemother. 1977 Aug;12(2):286–287. doi: 10.1128/aac.12.2.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sweet R. L., Yonekura M. L., Hill G., Gibbs R. S., Eschenbach D. A. Appropriate use of antibiotics in serious obstetric and gynecologic infections. Am J Obstet Gynecol. 1983 Jul 15;146(6):719–739. doi: 10.1016/0002-9378(83)91022-0. [DOI] [PubMed] [Google Scholar]
- Thompson R. L., Wright A. J. Cephalosporin antibiotics. Mayo Clin Proc. 1983 Feb;58(2):79–87. [PubMed] [Google Scholar]
- Thornsberry C., Sahm D. F. Effect of media and blood on the antimicrobial activity of cephalosporins on serogroup D streptococci: a review. Diagn Microbiol Infect Dis. 1984 Jun;2(3 Suppl):75S–84S. [PubMed] [Google Scholar]
- Wilson W. R., Henry N. K., Keys T. F., Anhalt J. P., Cockerill F. R., 3rd, Edson R. S., Geraci J. E., Hermans P. E., Muller S. M., Rosenblatt J. E. Empiric therapy with moxalactam alone in patients with bacteremia. Mayo Clin Proc. 1984 May;59(5):318–326. doi: 10.1016/s0025-6196(12)61427-x. [DOI] [PubMed] [Google Scholar]